Replies to post #106012 on Anavex Life Sciences Corp (AVXL)

[attilathehunt]

If rare diseases are the fastest way to approval then why didn't we start a trial for a rare disease 18 months ago? Based on the timetable, we would have been approved over 5 months ago and then prescribed for off-label for AD related insomnia.